Contract facts
NONEEO 14398 - ANTIGEN TESTING is a federal NONE award for 255-Network Contract Office 15 (36C255) held by Abbott Rapid Dx North America, LLC. Estimated value —. Related solicitation 36C25523Q0047.
Incumbent footprint
Public recordAbbott Rapid Dx North America, LLC — $42.8M obligated across 9,132 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25523D0015?
36C25523D0015 (EO 14398 - antigen testing) is a 255-Network Contract Office 15 (36C255) award with an estimated value of —, currently held by Abbott Rapid Dx North America, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C255-23-D-0015?
36C255-23-D-0015 is the dashed form of PIID 36C25523D0015 (EO 14398 - antigen testing), held by Abbott Rapid Dx North America, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25523D0015?
255-Network Contract Office 15 (36C255) awarded 36C25523D0015 to Abbott Rapid Dx North America, LLC.
Who is the incumbent on 36C25523D0015?
Abbott Rapid Dx North America, LLC is the incumbent with $42.8M across 9132 related awards in SCOUT’s public footprint.
When does Abbott Rapid Dx North America, LLC’s 36C25523D0015 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.